Voyager Therapeutics (VYGR) reported new data from its two preclinical programs targeting tau for the treatment of Alzheimer’s disease. Data on tau silencing gene therapy VY1706 and anti-tau ...
March 31, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today reported new data from ...
A total of 1095 guests have reviewed Voyager of the Seas, giving it a rating of 4.1 on a scale of 1-5. Wonderful Apr 3rd, 2025 It was a girls get away we didn’t na e to cook or clean up it mess ...
Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback